Abstract:Therapeutic options on myocarditis are currently limited. Inhibition of Calpains have been shown to prevent CVB3-induced cardiac injuries, but the underlying mechanism has not been identified. Here, we examined whether NLRP3 inflammasome participates in CVB3-induced myocarditis and investigated the effects of Calpain-1 on CVB3-induced cardiac injury. NLRP3 inflammasome was activated in CVB3-infected hearts, evidenced by elevated protein levels of NLRP3, N-terminal domain of Gasdermin D, cleaved caspase-1, and increased colocalization of NLRP3 and ASC. Selectively inhibiting the activation of NLRP3 inflammasome by treating mice with MCC950 intraperitoneally decreased serum levels of CK-MB, LDH, IL-18, IL-1beta, prevented infiltration of inflammatory cells, and improved cardiac function in the setting of CVB3 infection. Meanwhile, transgenic mice overexpressing the endogenous Calpain inhibitor, Calpastatin (Tg-CAST) not only showed decreased apoptosis, inflammation, fibrosis, and enhanced cardiac function, but also exhibited inhibition of NLRP3 inflammasome and pyroptosis. Also, in vitro selectively inhibiting Calpain-1 with PD151746 protected cardiomyocytes from CVB3 infection with downregulated NLRP3 inflammasome and preserved cell viability. Mechanistically, we showed that mitochondrial dysfunction preceded inflammatory response after CVB3 treatment, and eliminating mitochondrial ROS over-produced by CVB3 with mito-TEMPO recapitalized phenotype observed in Tg-CAST mice. More directly, Tg-CAST mice presented alleviated mitochondrial dysfunction, and upregulation or inhibition of Calpain-1 activation in vitro regulated the mitochondrial respiration chain. Mito-TEMPO reversed the promoting effect of Calpain-1 on cell viability and NLRP3 inflammation. We also found that it was the mitochondrial Calpain-1, which was increased after CVB3 stimulation that activated NLRP3 inflammasome and resulted in cell death. Furthermore, ATP synthase-alpha (ATP5A1) was revealed to be the cleaving target of Calpain-1 after CVB3 treatment. Downregulating ATP5A1 with siATP5A1 impaired mitochondrial function, decreased cell viability and induced NLRP3 inflammasome. Taken together, these findings indicate that CVB3 infection induced Calpain-1 accumulation in mitochondria, resulted in ATP5A1 cleavage, mitochondrial ROS overproduction, eventually leading to NLRP3 inflammasome activation and pyroptosis, confirming the roles of Calpain in viral myocarditis and suggesting novel mechanisms. As a result, targeting Calpain appears a promising approach for the treatment of patients with viral myocarditis.

Abstract P274: Cardiac-Specific Knockout of Capn4 Attenuates Myocardial Remodeling and Improves Function after Myocardial Infarction in Mice

Deficiency of Capn4 Gene Inhibits Nuclear Factor-κB (NF-κB) Protein Signaling/Inflammation and Reduces Remodeling after Myocardial Infarction

Myeloid-specific deletion of Capns1 attenuates myocardial infarction injury via restoring mitochondrial function and inhibiting inflammasome activation.

Deletion of Capn4 Protects the Heart Against Endotoxemic Injury by Preventing ATP Synthase Disruption and Inhibiting Mitochondrial Superoxide Generation

Metabolomic and transcriptomic studies of improvements in myocardial infarction due to Pycr1 deletion

Over-expression of calpastatin attenuates myocardial injury following myocardial infarction by inhibiting endoplasmic reticulum stress.

Disruption of calpain reduces lipotoxicity-induced cardiac injury by preventing endoplasmic reticulum stress.

CaMKII/calpain Interaction Mediates Ischemia/reperfusion Injury in Isolated Rat Hearts

Calpain: the regulatory point of myocardial ischemia-reperfusion injury

E64d Deteriorates Post-Myocardial Infarction Left Ventricular Remodelling by Inhibiting Cathepsin S-Mediated Fibroblast Trans-Differentiation

Over-expression of Calpastatin Inhibits Calpain Activation and Attenuates Myocardial Dysfunction During Endotoxaemia.

PS-B06-5: MITOCHONDRIAL CALPAIN-1 ACTIVATES NLRP3 INFLAMMASOME VIA CLEAVING ATP5A1 AND INDUCING MITOCHONDRIAL ROS IN CVB3-INDUCED MYOCARDITIS

Association Between Myocardial Calpain Activation and Apoptosis in Lipopolysaccharide-Induced Septic Mouse Model

Calpain inhibitor MDL 28170 protects against the Ca2+ paradox in rat hearts.

Calmodulin-dependent Cyclic Nucleotide Phosphodiesterase in an Experimental Rat Model of Cardiac Ischemia-Reperfusion.

Cathepsin D Haploinsufficiency Exacerbates Post Myocardial Infarction Cardiac Remodeling and Malfunction by Impairing Autophagosome Removal

Increased Calpain-1 in Mitochondria Induces Dilated Heart Failure in Mice: Role of Mitochondrial Superoxide Anion

Calpain-mediated protein targets in cardiac mitochondria following ischemia–reperfusion

Abrogation of CC Chemokine Receptor 9 Ameliorates Ventricular Electrical Remodeling in Mice After Myocardial Infarction

Abstract P336: Endogenous Alpha-1a Adrenergic Receptors Promote Cardiomyocyte Survival Through Suppression Of Rip Kinase-mediated Necroptosis

Targeting CaMKII-9 Ameliorates Cardiac Ischemia/Reperfusion Injury by Inhibiting Myocardial Inflammation